We will be exhibiting at BioJapan 2024.

Using neurons as bio-digital sensors. Toxicity prediction using a digital library. High-throughput device using MEA.

Microchannel technology enables compartmentalization and co-culture. Compatibility with other companies' MEAs allows for the recording of electrical activity. Determination of toxicity and efficacy through the creation of digital signatures of compounds tested on innervated target organs. Prediction of toxicity and efficacy by comparing digital signatures of compounds using a digital library.

• Culture vessel

Frozen storage bags for blood products, antibody drugs, vaccines, and biosimilars.

The products are manufactured in a controlled environment compliant with ISO 7 by specially trained personnel. Some of the products adhere to strict quality control protocols, including particle count, microscopic observation, and individual bag pressure tests.

• Culture vessel

EVA freezing storage bag (-196℃). Made by TECHNOFLEX (France). Compliant with USP Class 6 and ISO 10993.

EVA-based high-frequency welded tubes and connectors ensure the integrity of a completely sealed system once filling is complete. This process is already used in Technoflex's sterilization bags, preventing the risk of contamination and issues related to the transfer between the container and its contents, while also controlling the assembly costs of the fillers. EVA bags manufactured in an ISO 8 cleanroom undergo numerous tests in accordance with good manufacturing practices, including endotoxin level assessments and airtightness tests. The capacity of the bags ranges from 5 to 500 ml. Sterilization using beta or gamma rays is also available upon request. Technoflex provides global "all-in-one" sterilization for bags, tubes, and connectors.

• Human cells

FEP-made cell culture bags. Manufactured by TECHNOFLEX (France). Compliant with USP Class 6. DMF registered.

The SafeCell series is made of fluorinated ethylene propylene (FEP) and meets the demands of in vitro cell culture. FEP is chemically and biologically inert, making it perfectly suitable for cell suspension culture. Its anti-adhesion properties allow cells to freely float and proliferate in the medium. SafeCell bags are permeable to gases (oxygen, carbon dioxide, nitrogen), enabling the necessary exchanges for proper cell development, while also possessing another important characteristic: water impermeability. The low evaporation rate of SafeCell bags prevents issues even in humid incubators that increase the risk of bacterial and microbial growth.

• Culture vessel

Reliable single-use bags required for sterile processes such as storage and transportation of media, intermediates, buffers, etc., used in biopharmaceuticals.

AsptiBag Gold uses an inactive multilayer polyethylene film that is physically robust and inert to many chemicals and solvents, while also possessing excellent gas barrier properties. The contact surface is made of 130μm ultra-low-density polyethylene without any additives. It meets various regulatory and functional requirements, providing consistently high-quality products.

• Other bio-related products

To reduce contamination risks and streamline the cleaning process.

Single-use assembly tubes for biopharmaceuticals. Tube material, length, connector type, filters, etc. can be customized according to customer requirements. Manufactured in a Class 7 cleanroom. The facility is ISO 13485 and FDA certified. Compatible with gamma sterilization, with various certificates included.

• Filtration Filter

Sterilization applications for biopharmaceuticals and sterile preparations! Filters with high microbial retention, low protein adsorption, and extremely low elution performance.

Advanced Microdevices' sterilizing capsule filter achieves improved throughput through a pre-filter and high flow rates due to low hold-up volume. 【Features】 ■ Improved recovery rate due to low protein adsorption ■ Assurance of microbial capture performance through bacteria challenge testing ■ 100% integrity testing conducted ■ Certificate provided with each filter ■ Compatible with ethylene oxide and autoclave sterilization ■ Gamma radiation sterilization compatible

• Other bio-related products

Gamma-ray irradiated disposable sampling system. Customizable.

The sterile sampling system can be customized to meet user requirements for tube size, sampling ports, and sampling containers.

• Other bio products

Stirring bag for biopharmaceuticals. With stirrer. Single-use.

Single-use mixing bags are designed for quick and uniform mixing. An impeller is attached to the bottom of the bag and rotates via a magnetic drive. It can accommodate bag capacities of up to 1000L. A 4-inch or 8-inch port can be installed on the top. It is also compatible with sanitary flanges. The bags are customizable.

• Culture vessel

No need for centrifugation‼ Cultivation filtration depth filter

The combination of deep filtration and alluvial filtration allows for the removal of CHO cells, bacteria, etc., in a single step without the need for a centrifugation step. This reduces the cost and downtime of the bioprocess.

• Protein Extraction Kit

Pre-use post-sterilization integrity testing support filling line

We assemble various single-use parts such as tubes, bags, filters, filling needles, and RTP ports according to your requirements. After assembly, they can be sterilized and delivered. The parts undergo various tests and validations based on guidelines.

• Bio-related product packaging machine

Alternative methods to animal testing: Pyrogenic substance testing (compatible with endotoxin and non-endotoxin testing)

Monocyte activation test kit, an alternative method to the rabbit pyrogen test and LAL test. It uses human monocytic THP-1 cells to detect the inflammatory cytokine TNF-α. Capable of detecting gram-negative bacteria, gram-positive bacteria, fungi, and viruses.

• Other analytical and testing equipment

A biomimetic system that tests by moving cultivated mini-organs.

Mechanical stimulation of cultured tissues such as 3D cardiac microtissues using actuators to mimic heartbeats and knee joint movements. Evaluation of changes in electrical activity after drug administration allows for in vitro safety assessment of drugs. *Measurement of heart rate, electrical activity, contractility, etc.

• Cell culture contract service

We will be exhibiting at the joint company information session hosted by Mynavi on the following schedule. We will clearly explain the four core businesses of Takaya. If you are interested in "monozukuri" (manufacturing), please come to our booth!

At this exhibition, we will introduce our materials equipped with new functions and values that contribute to solving our customers' challenges. Our mid-term management plan includes "securing competitive advantage through technology leadership" as one of its basic strategies, and our engineers, who embody this strategy, will explain and propose the exhibited products in their own words. We would love to hear your feedback, so please feel free to stop by our booth.

[Speaker] Naoki Toda, Chief Economist, Management Strategy Research Office, Tokyo Electric Power Company Holdings, Inc. [Key Lecture Content] Since the 1990s, the global advancement of power system reforms has aimed for efficiency and optimization in both the operation and investment of facilities through active market competition. However, with the progress of DX/GX, the anticipated scenarios for electricity demand have led to the emergence of underinvestment issues worldwide. The IEA's report "Electricity Market Design," published last year, provides a comprehensive review of the reform situations in various countries and indicates that the underinvestment problem is a common issue across the globe. In this lecture, I will explain the current state of the underinvestment issue and potential responses from a business system perspective, referencing the IEA report and others. [Lecture Items] 1. Background of power system reforms and the underinvestment issue 2. About IEA "Electricity Market Design" 3. Reflecting on the thoughts of Akihiro Sawa on the 10th anniversary of his passing 4. Possible solutions to the Tenor Gap issue 5. Outlook for Japan's power system 6. Q&A / Business card exchange

[Instructor] Shinichiro Takiguchi, Senior Specialist, Innovation Strategy Center, Japan Research Institute, Inc. [Key Lecture Content] With the increase in renewable energy, the introduction of energy storage systems has progressed in two forms: renewable energy co-located systems to adjust power generation fluctuations, and demand co-located systems to secure electricity during grid outages. However, the landscape is changing significantly. The "Supply and Demand Adjustment Market" has been established by OCTTO (Organization for Cross-regional Coordination of Transmission Operators), and particularly due to the continued high pricing agreements in the short-term response market (primary adjustment power responding within 10 seconds), there have been numerous cases where battery storage profits are secured through market transactions. In the grid energy storage business, two capabilities are required: "trading power" and "financial power." This lecture will explain the business structure and key points of profitability. Additionally, based on this business structure, we will classify the companies entering the grid energy storage business and organize the market structure of this sector. As this business is influenced by regulatory trends, we will also discuss regulatory outlooks. Finally, we will talk about future prospects.

[Lecturer] Professor Yoshiharu Nishimura, Senior Researcher, Kansai Electric Power Co., Inc. Graduate School of Engineering, Osaka University, Business Engineering Program [Key Lecture Content] The examination of the next-generation power infrastructure conducted in 2025 has entered the implementation phase, including amendments to the Electricity Business Act, towards a new power policy standard (a sustainable framework by responsible players) in 2026. This lecture will outline the content and related policy adjustments for businesses involving renewable energy and storage batteries, and consider the correct business concepts, necessary timelines, and how to create business models moving forward. [Lecture Items] 1. What is the 2026 Next-Generation Power Infrastructure Reconstruction? 2. Renewable Energy and Decarbonization Policies and Issues with Chinese Products 3. The Latest Status of Storage Batteries and the Timeline and Vision for DER Business 4. Q&A / Business Card Exchange